Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Intravenous Dexamethasone Palmitate for the Prevention of Postherpetic Neuralgia in Acute and Subacute Herpes Zoster Patients: Study Protocol for a Randomized, Prospective, Multicenter, Three-arm, Open-label Controlled Trial

NCT07344246 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT07344246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07344246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Intravenous Dexamethasone Palmitate for the Prevention of Postherpetic Neuralgia in Acute and Subacute Herpes Zoster Patients: Study Protocol for a Randomized, Prospective, Multicenter, Three-arm, Open-label Controlled Trial
Lead sponsor
Beijing Tiantan Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 1, 2028
Enrollment
954 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster pain